232 related articles for article (PubMed ID: 34235533)
1. Novel anti-GARP antibody DS-1055a augments anti-tumor immunity by depleting highly suppressive GARP+ regulatory T cells.
Satoh K; Kobayashi Y; Fujimaki K; Hayashi S; Ishida S; Sugiyama D; Sato T; Lim K; Miyamoto M; Kozuma S; Kadokura M; Wakita K; Hata M; Hirahara K; Amano M; Watanabe I; Okamoto A; Tuettenberg A; Jonuleit H; Tanemura A; Maruyama S; Agatsuma T; Wada T; Nishikawa H
Int Immunol; 2021 Jul; 33(8):435-446. PubMed ID: 34235533
[TBL] [Abstract][Full Text] [Related]
2. Anti-CCR4 mAb selectively depletes effector-type FoxP3+CD4+ regulatory T cells, evoking antitumor immune responses in humans.
Sugiyama D; Nishikawa H; Maeda Y; Nishioka M; Tanemura A; Katayama I; Ezoe S; Kanakura Y; Sato E; Fukumori Y; Karbach J; Jäger E; Sakaguchi S
Proc Natl Acad Sci U S A; 2013 Oct; 110(44):17945-50. PubMed ID: 24127572
[TBL] [Abstract][Full Text] [Related]
3. Selective targeting of GARP-LTGFβ axis in the tumor microenvironment augments PD-1 blockade via enhancing CD8
Li A; Chang Y; Song NJ; Wu X; Chung D; Riesenberg BP; Velegraki M; Giuliani GD; Das K; Okimoto T; Kwon H; Chakravarthy KB; Bolyard C; Wang Y; He K; Gatti-Mays M; Das J; Yang Y; Gewirth DT; Ma Q; Carbone D; Li Z
J Immunother Cancer; 2022 Sep; 10(9):. PubMed ID: 36096533
[TBL] [Abstract][Full Text] [Related]
4. GARP Dampens Cancer Immunity by Sustaining Function and Accumulation of Regulatory T Cells in the Colon.
Salem M; Wallace C; Velegraki M; Li A; Ansa-Addo E; Metelli A; Kwon H; Riesenberg B; Wu B; Zhang Y; Guglietta S; Sun S; Liu B; Li Z
Cancer Res; 2019 Mar; 79(6):1178-1190. PubMed ID: 30674536
[TBL] [Abstract][Full Text] [Related]
5. Garp as a therapeutic target for modulation of T regulatory cell function.
Shevach EM
Expert Opin Ther Targets; 2017 Feb; 21(2):191-200. PubMed ID: 28001437
[TBL] [Abstract][Full Text] [Related]
6. A key role of GARP in the immune suppressive tumor microenvironment.
Hahn SA; Neuhoff A; Landsberg J; Schupp J; Eberts D; Leukel P; Bros M; Weilbaecher M; Schuppan D; Grabbe S; Tueting T; Lennerz V; Sommer C; Jonuleit H; Tuettenberg A
Oncotarget; 2016 Jul; 7(28):42996-43009. PubMed ID: 27248166
[TBL] [Abstract][Full Text] [Related]
7. Fc-Optimized Anti-CCR8 Antibody Depletes Regulatory T Cells in Human Tumor Models.
Campbell JR; McDonald BR; Mesko PB; Siemers NO; Singh PB; Selby M; Sproul TW; Korman AJ; Vlach LM; Houser J; Sambanthamoorthy S; Lu K; Hatcher SV; Lohre J; Jain R; Lan RY
Cancer Res; 2021 Jun; 81(11):2983-2994. PubMed ID: 33757978
[TBL] [Abstract][Full Text] [Related]
8. Activated glycoprotein A repetitions predominant (GARP)-expressing regulatory T cells inhibit allergen-induced intestinal inflammation in humanized mice.
Eschborn M; Weigmann B; Reissig S; Waisman A; Saloga J; Bellinghausen I
J Allergy Clin Immunol; 2015 Jul; 136(1):159-68. PubMed ID: 26145987
[TBL] [Abstract][Full Text] [Related]
9. Monoclonal antibodies against GARP/TGF-β1 complexes inhibit the immunosuppressive activity of human regulatory T cells in vivo.
Cuende J; Liénart S; Dedobbeleer O; van der Woning B; De Boeck G; Stockis J; Huygens C; Colau D; Somja J; Delvenne P; Hannon M; Baron F; Dumoutier L; Renauld JC; De Haard H; Saunders M; Coulie PG; Lucas S
Sci Transl Med; 2015 Apr; 7(284):284ra56. PubMed ID: 25904740
[TBL] [Abstract][Full Text] [Related]
10. CD4
Wei Y; Yu K; Wei H; Su X; Zhu R; Shi H; Sun H; Luo Q; Xu W; Xiao J; Zhong Y; Zeng Q
Immunology; 2017 Jul; 151(3):291-303. PubMed ID: 28207945
[TBL] [Abstract][Full Text] [Related]
11. Feline glycoprotein A repetitions predominant anchors transforming growth factor beta on the surface of activated CD4(+)CD25(+) regulatory T cells and mediates AIDS lentivirus-induced T cell immunodeficiency.
Miller MM; Fogle JE; Ross P; Tompkins MB
AIDS Res Hum Retroviruses; 2013 Apr; 29(4):641-51. PubMed ID: 23373523
[TBL] [Abstract][Full Text] [Related]
12. GARP as a Therapeutic Target for the Modulation of Regulatory T Cells in Cancer and Autoimmunity.
Zimmer N; Trzeciak ER; Graefen B; Satoh K; Tuettenberg A
Front Immunol; 2022; 13():928450. PubMed ID: 35898500
[TBL] [Abstract][Full Text] [Related]
13. Blocking GARP-mediated activation of TGF-β1 did not alter innate or adaptive immune responses to bacterial infection or protein immunization in mice.
Gaignage M; Zhang X; Stockis J; Dedobbeleer O; Michiels C; Cochez P; Dumoutier L; Coulie PG; Lucas S
Cancer Immunol Immunother; 2022 Aug; 71(8):1851-1862. PubMed ID: 34973084
[TBL] [Abstract][Full Text] [Related]
14. [Immunosuppression by Treg can be decreased with anti-GARP antibodies].
Lucas S
Med Sci (Paris); 2015 Oct; 31(10):832-4. PubMed ID: 26481020
[No Abstract] [Full Text] [Related]
15. GARP Correlates With Tumor-Infiltrating T-Cells and Predicts the Outcome of Gastric Cancer.
Jiang S; Zhang Y; Zhang X; Lu B; Sun P; Wu Q; Ding X; Huang J
Front Immunol; 2021; 12():660397. PubMed ID: 34421887
[TBL] [Abstract][Full Text] [Related]
16. Regulatory T cells in cancer immunotherapy.
Tanaka A; Sakaguchi S
Cell Res; 2017 Jan; 27(1):109-118. PubMed ID: 27995907
[TBL] [Abstract][Full Text] [Related]
17. CD122-Selective IL2 Complexes Reduce Immunosuppression, Promote Treg Fragility, and Sensitize Tumor Response to PD-L1 Blockade.
Drerup JM; Deng Y; Pandeswara SL; Padrón ÁS; Reyes RM; Zhang X; Mendez J; Liu A; Clark CA; Chen W; Conejo-Garcia JR; Hurez V; Gupta H; Curiel TJ
Cancer Res; 2020 Nov; 80(22):5063-5075. PubMed ID: 32948605
[TBL] [Abstract][Full Text] [Related]
18. Suppressive IL-17A
Downs-Canner S; Berkey S; Delgoffe GM; Edwards RP; Curiel T; Odunsi K; Bartlett DL; Obermajer N
Nat Commun; 2017 Mar; 8():14649. PubMed ID: 28290453
[TBL] [Abstract][Full Text] [Related]
19. Targeting of Cdc42 GTPase in regulatory T cells unleashes antitumor T-cell immunity.
Kalim KW; Yang JQ; Wunderlich M; Modur V; Nguyen P; Li Y; Wen T; Davis AK; Verma R; Lu QR; Jegga AG; Zheng Y; Guo F
J Immunother Cancer; 2022 Nov; 10(11):. PubMed ID: 36427906
[TBL] [Abstract][Full Text] [Related]
20. GARP-TGF-β complexes negatively regulate regulatory T cell development and maintenance of peripheral CD4+ T cells in vivo.
Zhou AX; Kozhaya L; Fujii H; Unutmaz D
J Immunol; 2013 May; 190(10):5057-64. PubMed ID: 23576681
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
